FITY
Fifty 1 Labs Inc.

MELBOURNE, Florida, December 10, 2024 — Following its recent announcement of the cancellation of 200 million common shares, Consumer Automotive Finance, Inc. (OTCPK: CAFI), a dynamic company active in the sports supplement, fitness equipment, and health and wellness sectors, is pleased to announce the cancellation of an additional 50 million common shares. This move further underscores the Company’s dedication to optimizing its capital structure and enhancing long-term shareholder value.

In addition, a key shareholder has committed to retiring an additional 250 million common shares in the near future. These efforts collectively represent a transformative step in the Company’s ongoing mission to streamline its share structure and position itself for sustained growth and success. When successful in eliminating 300 Million Common shares the company expects its issued and outstanding share count to be 262,978,600.

“This latest cancellation of 50 million shares, along with the commitment from a shareholder to retire 250 million more, is a testament to our shared vision for a stronger, more efficient company,” said Robert Clark, CEO of Consumer Automotive Finance, Inc. “These initiatives demonstrate our continued focus on improving equity value for our shareholders and building a solid foundation for long-term success. We are committed to driving meaningful change that benefits all stakeholders.”

The announcement follows the Company’s progress in its rebranding efforts. Consumer Automotive Finance, Inc. is in the process of transitioning to Fifty 1 Labs, Inc., with its anticipated new ticker symbol “FITY.” This rebranding initiative, currently under review by FINRA, reflects the Company’s evolving mission and focus on innovation in the sports nutrition and wellness sectors.

The Company also announced it recently filed Form 15c2-11 with the U.S. Securities and Exchange Commission (SEC), marking a significant step toward improving its financial transparency and compliance. This filing is required by the SEC to enable a company to maintain its quotation on the Over-the-Counter (OTC) Markets.

“Our strategic actions, including the reduction of our outstanding shares and the upcoming transition to Fifty 1 Labs, Inc. along with the filing of our 15c2-11, reflect our commitment to aligning our operations with our growth-oriented vision,” Clark added. “We are building momentum and positioning ourselves as a leader in the health and wellness space.”

Lastly, the Company is actively taking the necessary steps to remove the yield sign from OTC by submitting its annual disclosure opinion letter. This process includes a scheduled call with all directors and our legal counsel, ensuring full compliance and transparency to strengthen investor confidence.  The Company anticipates it will have the opinion letter posted in the coming days.

About Fifty 1 Labs, Inc.

Consumer Automotive Finance, Inc. (OTCPK: CAFI), soon to be renamed Fifty 1 Labs, Inc., is a publicly traded company focused on sports supplementation, fitness equipment, and holistic wellness. The company operates four key subsidiaries: 51, LLC, which specializes in sports supplements; The Quickness, which offers patented athletic training equipment; Astound NMN, a leader in anti-aging and DNA repair supplements; and Drago Knives, patented knife throwing technology. Fifty 1 Labs, Inc. is also actively pursuing strategic acquisitions to expand its portfolio and drive sustainable growth.

Safe Harbor Statement:

The information provided in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Identifiable by words such as "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions, these statements may also be made in written or oral form in the company's filings with the U.S. Securities and Exchange Commission, OTC Markets, press releases, other written materials, or in oral statements made by its officers, directors, or employees to third parties. There can be no assurance that such statements will prove to be accurate. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company's Disclosure Statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the company's control. The company does not undertake any obligation to update publicly or to revise any statements in this release, whether as a result of new information, future events, or otherwise.

Investor Relations Contact:

Investor Relations

844-714-2224

ir@fifty1labs.com